Atlas Trials

Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS

Clinical trial NCT04741945 · RECRUITING

Trial details

NCT number
NCT04741945
Sponsor
Kirsten Grønbæk
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
PreleukemiaMyelodysplastic NeoplasmCytopeniaPreleukemic Anemia
Start date
2021-12-13
Primary completion
2026-02-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.